Daily non-political popular news in brief.

Taking the wraps off drug safety data from clinical trials

A new analysis by researchers at the Harvard School of Public Health (HSPH) and Brigham and Women's Hospital (BWH) of laws and regulations governing public disclosure of clinical trial data submitted to the Food and Drug Administration suggests changes should be made to the way the FDA implements its policy regarding the confidentiality of those data.

Read more »

Keywords: taking, wraps, drug, safety, data, clinical, trials, wrap, trial

« Previous | Next »

Similar news on "Taking the wraps off drug safety data from clinical trials":

1. International AIDS Vaccine Initiative (IAVI) statement on male circumcision
   12-14-2006 · EurekAlert!
   The International AIDS Vaccine Initiative (IAVI) issued this statement today following a National Institutes of Health (NIH) decision to end two clinical trials of adult male circumcision in Uganda and Kenya. The NIH's Data Safety and Monitoring Board (DSMB), reviewing interim data, found that medically performed circumcision significantly protected men in the trial from HIV infection.
   Similar news · Read more »
   
2. Drug interactions with warfarin
   08-13-2007 · EurekAlert!
   This real-world study of prescription data from general practices observed much higher rates of bleeding than those derived from a meta-analysis of randomized clinical trials. The authors write that physicians should be aware of these risks to better assess their patients' therapeutic risk-benefit profiles.
   Similar news · Read more »
   
3. Clinical trial data: Safety/efficacy of concomitant formoterol fumarate/tiotropium treating COPD
   10-24-2007 · EurekAlert!
   Data presented today at CHEST 2007, the annual scientific assembly of the American College of Chest Physicians, demonstrate concomitant use of nebulized formoterol fumarate and tiotropium provided improved bronchodilation over tiotropium monotherapy and was well-tolerated in this clinical study.
   Similar news · Read more »
   
4. Drug-based on MGH discovery may significantly improve treatment of dangerous blood disorder
   01-31-2008 · EurekAlert!
   Two clinical trials of the novel drug romiplostim show that it significantly improved platelet levels in patients with chronic immune thrombocytopenic purpura, a hematologic disorder that can cause uncontrolled bleeding. An international research team reports Phase 3 trial results for the drug, which duplicates the action of a natural hormone discovered by a Massachusetts General Hospital investigator, in the Feb. 2 issue of The Lancet.
   Similar news · Read more »
   
5. Promising Antiobesity Drug Fails To Produce Clinically Meaningful Weight Loss
   10-05-2006 · ScienceDaily
   A drug designed to target a powerful hunger-stimulating factor that has long been considered a prime target for antiobesity therapy failed to produce clinically meaningful weight loss in obese people in a long-term clinical trial. People taking the drug known as MK-0557 for a year consistently lost about three pounds more than those taking a placebo, researchers reported in the October issue of the journal Cell Metabolism, published by Cell Press.
   Similar news · Read more »
   
6. Clinical trials nebulized formoterol fumarate: Long-term and cardiovascular safety COPD
   10-24-2007 · EurekAlert!
   Data from two Phase III clinical trials were presented today in Chicago at CHEST 2007, the annual scientific assembly of the American College of Chest Physicians, supporting the use of Perforomist Inhalation Solution as a safe and effective maintenance treatment for COPD patients.
   Similar news · Read more »
   
7. Drug-eluting and bare-metal stents equal in risk of blood clots, heart attacks and death
   03-24-2007 · EurekAlert!
   Although the use of stents to treat coronary artery disease has soared during the past decade thanks to novel equipment and new implant techniques, clinical data has recently raised concerns around the safety of drug-eluting stents (DES) and their risk of post-procedure complications. A study presented today at the American College of Cardiology’s Innovation in Intervention: i2 Summit compared rates of complications in thousands of patients who received bare-metal stents (BMS) or DES.
   Similar news · Read more »
   
8. Drug based on MGH discovery may significantly improve treatment of dangerous blood disorder
   01-31-2008 · EurekAlert!
   Two clinical trials of the novel drug romiplostim show that it significantly improved platelet levels in patients with chronic immune thrombocytopenic purpura, a hematologic disorder that can cause uncontrolled bleeding. An international research team reports Phase 3 trial results for the drug, which duplicates the action of a natural hormone discovered by a Massachusetts General Hospital investigator, in the Feb. 2 issue of the Lancet.
   Similar news · Read more »
   
9. Novel therapy for lipid disorders shows mixed results in early clinical trials
   03-25-2007 · EurekAlert!
   Preliminary research suggests that use of a novel, potent drug to treat cholesterol disorders decreases triglycerides and increases HDL-C, the "good" cholesterol, but also raises some safety concerns, according to a study in the March 28 issue of JAMA. The study is being released early to coincide with its presentation at the American College of Cardiology's annual conference.
   Similar news · Read more »
   
10. Clinical trial data for Perforomist Inhalation Solution to be presented at ATS on May 20, 2007
    05-16-2007 · EurekAlert!
    Clinical trial data for Perforomist Inhalation Solution will be presented at ATS on May 20, 2007. Data from Phase III pivotal trial demonstrates safety and efficacy of first FDA-approved nebulized formoterol fumarate for patients with moderate to severe COPD.
    Similar news · Read more »